|Haw Par Corporation Limited -- USA Stock|| |
USD 26.2 0.00 0.00%
Non-Executive Independent Director
Dr. Lee Suan Yew is NonExecutive Independent Director of Haw Par Corporationrationration Ltd. He is a medical practitioner with over 50 years experience. He was appointed to the Board on 18 December 1995 and was last reappointed on 29 April 2016. He is a member of the Nominating Committee. Dr Lee is a Director of K1 Ventures Limited. He was appointed Justice of the Peace from 1998 2008. Dr Lee was President of the Singapore Medical Council for 4 years and was also Chairman of the Singapore National Medical Ethics Committee . For his numerous public services, he was awarded the Public Service Star in 1991 and Public Service Star in 2002. He holds a M.B.B. Chir. degree from the University of Cambridge and MRCP and FRCP from the Royal College of Physicians, Glasgow.
Age: 82 Director Since 1995 Ph.D
65 6337 9102 http://www.hawpar.com
The company has return on total asset (ROA)
of 1.52 %
which means that it generated profit of $1.52 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 3.2 %
meaning that it generated $3.2 on every $100 dollars invested by stockholders.
The company has accumulated 34.64 M in total debt with debt to equity ratio (D/E) of 0.02 which may suggest the company is not taking enough advantage from borrowing. Haw Par Corporation Limited has Current Ratio of 6.03 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Haw Par Corporationration Limited, together with its subsidiaries, manufactures, markets, and trades healthcare products; offer leisurerelated goods and services; and invests in properties and securities. Haw Par Corporation Limited (HAWPY) is traded on OTC Market in USA. It is located in Singapore, and employs 546 people.